Please assess the completion status of the following clinical trial:

Trial Title: A Study to Test if TEV-48574 is Effective in Relieving Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The participant has a diagnosis of asthma for at least 12 months prior to the initial screening visit.~* The participant is able to perform technically acceptable and repeatable spirometry, including with a hand-held spirometer, after training~* The participant has had at least one documented clinical asthma exacerbation in the 18 months prior to (but not within 30 days of) the initial screening visit.~* The participant is a non-smoker for ≥6 months with lifetime history ≤10 pack-years, with no current ecigarette or marijuana use.~NOTE- Additional criteria apply, please contact the investigator for more information~Exclusion Criteria:~* The participant has any concomitant conditions or treatments that could interfere with study conduct.~* The participant is currently pregnant or lactating or is planning to become pregnant during the study.~* The participant has received any live or attenuated vaccine within 15 days of the initial screening visit.~NOTE- Additional criteria apply, please contact the investigator for more information

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TEV-48574 (Type: EXPERIMENTAL): Participants will receive the investigational medicinal product (IMP) loading doses on the day of randomization and the subsequent corresponding IMP maintenance doses every 2 weeks for a total of 8 doses (1 loading dose and 7 maintenance doses).
- Placebo (Type: PLACEBO_COMPARATOR): Participants will receive placebo matching to TEV-48574 SC every 2 weeks for a total of 8 doses.

Based on this trial design, predict the completion outcome and termination type (if applicable).